Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →Managing comorbidities and treatment-related toxicities in cancer patients is crucial for ensuring treatment success, reducing complications, and improving quality of life. Conditions like diabetes, heart disease, and autoimmune disorders can worsen treatment side effects, leading to hospitalizations and therapy delays. Fast access to specialized care allows for early intervention, minimizing toxicities and optimizing treatment tolerance. A proactive, multidisciplinary approach ensures patients stay on therapy, reducing interruptions and improving long-term outcomes. Solution and value add: Connected care platforms, including telehealth and virtual consultations, ensure rapid access to specialists—such as endocrinologists, cardiologists, and rheumatologists—reducing delays in care. Additionally, AI-powered triage and decision-support tools can optimize clinical workflows, helping oncologists prioritize high-risk patients and tailor treatments accordingly. By enhancing early intervention, reducing hospitalizations, and improving patient outcomes, AI and connected care create a more efficient, proactive, and patient-centered oncology care model. Panelists will discuss integrated models, value proposition for these services and KPIs to measure success.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Dr. Afreen Idris Shariff is the Director of the Cancer Therapy Toxicity Program at Duke Cancer Institute, Co-Founder of Citrus Oncology, and Associate Professor of Medicine at Duke University.She is a recognized leader in Onco-Endocrinology, specializing in managing endocrine disorders in cancer patients and advancing AI-enabled care models to improve access, equity, and outcomes.Dr. Shariff serves on the Board of the Association of Cancer Care Centers (ACCC), ASCO’s Alliance for Support and Prevention of Immune-Related Adverse Events (ASPIRE) and hosts the globalmedical podcast Checkpoint NOW. Citrus Oncology started by Dr. Shariff in 2024 is an AI-enabled virtual side effect management platform that connects oncologists with clinical insights andsubspecialists—including endocrinologists, cardiologists, and dermatologists—within 72 hours delivering high-value, multidisciplinary care for cancer therapy toxicities and complexcomorbidities.
Dig into the research behind this topic — plain-English summaries written for BCBAs.
279 research articles with practitioner takeaways
258 research articles with practitioner takeaways
252 research articles with practitioner takeaways
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.